Clenbuterol 40 mcg is indicated for short-term management of bronchospasm. Off-label use for performance enhancement is associated with significant cardiovascular risk.

Clenbuterol 40 mcg is indicated for short-term management of bronchospasm. Off-label use for performance enhancement is associated with significant cardiovascular risk.